Nitrite reduces ischemia/reperfusion-induced muscle damage and improves survival rates in rat crush injury model

Journal of Trauma and Acute Care Surgery

Volumn 72, Issue 6, 2012, Pages 1548-1554

  Murata, Isamu ^a   Nozaki, Ryo ^a   Ooi, Kazuya ^b   Ohtake, Kazuo ^a   Kimura, Soichiro ^a   Ueda, Hideo ^d   Nakano, Genya ^a   Sonoda, Kunihiro ^c   Inoue, Yutaka ^a   Uchida, Hiroyuki ^a   Kanamoto, Ikuo ^a   Morimoto, Yasunori ^a   Kobayashi, Jun ^a  

^a JOSAI UNIVERSITY   (Japan)

^b SUZUKA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^c KINJO GAKUIN UNIVERSITY   (Japan)

^d NONE

Author keywords

Crush syndrome; Ischemia reperfusion; Nitric oxide; Nitrite

Indexed keywords

CREATINE KINASE; INTERLEUKIN 6; LACTATE DEHYDROGENASE; METHEMOGLOBIN; MYELOPEROXIDASE; NITRIC OXIDE; POTASSIUM; SODIUM NITRITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD ANALYSIS; CELL PROTECTION; CONTROLLED STUDY; CRUSH SYNDROME; ENZYME ACTIVITY; MALE; MEAN ARTERIAL PRESSURE; MUSCLE INJURY; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; RHABDOMYOLYSIS; SHAM PROCEDURE; SURVIVAL;

ANALYSIS OF VARIANCE; ANIMALS; BLOOD PRESSURE DETERMINATION; CRUSH SYNDROME; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEMODYNAMICS; HINDLIMB; INTERLEUKIN-6; KAPLAN-MEIER ESTIMATE; MALE; MUSCLE, SKELETAL; NITRITES; PEROXIDASE; RANDOM ALLOCATION; RATS; RATS, WISTAR; REFERENCE VALUES; REPERFUSION INJURY; RHABDOMYOLYSIS; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84864567181     PISSN: 21630755     EISSN: 21630763     Source Type: Journal    
DOI: 10.1097/TA.0b013e31824a76b5     Document Type: Article

References (22)

1. Bosch X, Poch E, Grau JM. Rhabdomyolysis and acute kidney injury. N Engl J Med. 2009;361:62-72.
2. Murata I, Ooi K, Sasaki H, et al. Characterization of systemic and histologic injury after crush syndrome and intervals of reperfusion in a small animal model. J Trauma. 2011;70:1453-1463.
3. Sever MS, Vanholder R, Lameire N. Management of crush-related injuries after disasters. N Engl J Med. 2006;354:1052-1063.
4. Huerta-Alardin AL, Varon J, Marik PE. Bench-to-bedside review: rhabdomyolysis-an overview for clinicians. Crit Care. 2005;9:158-169.
5. Duranski MR, Greer JJM, Dejam A, et al. Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver. J Clin Invest. 2005;115:1232-1240.
6. Dezfulian C, Raat N, Shiva S, Gladwin MT. Role of the anion nitrite in ischemia-reperfusion cytoprotection and therapeutics. Cardiovasc Res. 2007;75:327-338.
7. Ohtake K, Koga M, Uchida H, et al. Oral nitrite ameliorates dextrin sulfate sodium-induced acute experimental colitis in mice. Nitric Oxide. 2010; 23:65-73.
8. Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol. 1982;78:206-209.
9. McNulty PH, Scott S, Kehoe V, Kozak M, Sinoway LI, Li J. Nitrite consumption in ischemic rat heart catalyzed by distinct blood-borne and tissue factors. Am J Physiol Heart Circ Physiol. 2008;295:H2143-H2148.
10. Raat NJH, Shiva S, Gladwin MT. Effects of nitrite on modulating ROS generation following ischemia and reperfusion. Adv Drug Deliv Rev. 2009;61:339-350.
11. Shiva S, Huang Z, Grubina R, et al. Deoxymyoglobin is a nitrite reductase that generates nitric oxide and regulates mitochondrial respiration. Circ Res. 2007;100:654-661.
12. Hendgen-Cotta UB, Merx MW, Shiva S, et al. Nitrite reductase activity of myoglobin regulates respiration and cellular viability inmyocardial ischemiareperfusion injury. Proc Natl Acad Sci U S A. 2008;105:10256-10261.
13. Rassaf T, Flogel U, Drexhage C, Hendgen-Cotta U, Kelm M, Schrader J. Nitrite reductase function of deoxymyoglobin. Oxygen sensor and regulator of cardiac energetic and function. Circ Res. 2007;100:1749-1754.
14. Hendgen-Cotta UB, Kelm M, Rassaf T. A highlight of myoglobin diversity: the nitrite reductase activity during myocardial ischemiareperfusion. Nitric Oxide. 2010;22:75-82.
15. Bryan NS, Calvert JW, Elrod JW, Gundewar S, Ji SY, Lefer DJ. Dietary nitrite supplementation protects against myocardial ischemia-reperfusion injury. Proc Natl Acad Sci U S A. 2007;104:19144-19149.
16. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;39:44-84.
17. Biffl WL, Moore EE, Moore FA, Peterson VM. Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation? Ann Surg. 1996; 224:647-664.
18. Gebhard F, Pfetsch H, Steinbach G, Strecker W, Kinzl L, Bruckner UB. Is interleukin 6 an early marker of injury severity following major trauma in humans? Arch Surg. 2000;135:291-295.
19. Youker K, SmithCW, Anderson DC, et al. Neutrophil adherence to isolated adult cardiac myocytes. Induction by cardiac lymph collected during ischemia and reperfusion. J Clin Invest. 1992;89:602-609.
20. Kukielka GL, Youker KA, Hawkins HK, et al. Regulation of ICAM-1 and IL-6 in myocardial ischemia: effect of reperfusion. Ann N Y Acad Sci. 1994;574:258-270.
21. Cauwels A, Buys ES, Thoonen R, et al. Nitrite protects against morbidity and mortality associated with TNF- or LPS-induced shock in a soluble guanylate cyclase-dependent manner. J Exp Med. 2009;206:2915-2924.
22. Cauwels A, Brouckaert P. Nitrite regulation of shock. Cardiovasc Res. 2011;89:553-559.